Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population

Ganesh B. Chand, Pankhuri Singhal, Dominic Dwyer, Junhao Wen, Güray Erus, Jimit Doshi, Dhivya Srinivasan, Elizabeth Mamourian, Erdem Varol, Aristeidis Sotiras, Gyujoon Hwang, Paola Dazzan, René S. Kahn, Hugo G. Schnack, Marcus V. Zanetti, Eva Meisenzahl, Geraldo F. Busatto, Benedicto Crespo‐Facorro, Christos Pantelis, Stephen J. Wood, Chuanjun Zhuo, Russell T. Shinohara, Haochang Shou, Yong Fan, Nikolaos Koutsouleris, Antonia N. Kaczkurkin, Tyler M. Moore, Anurag Verma, Monica E. Calkins, Raquel E. Gur, Ruben C. Gur, Marylyn D. Ritchie, Theodore D. Satterthwaite, Daniel H. Wolf, Christos DavatzikosAmerican 2022 · DOI

Abstract

The prevalence and significance of schizophrenia-related phenotypes at the population-level are debated. This study assesses whether two recently reported neuroanatomical signatures of schizophrenia—Signature 1 (widespread reduction of gray matter volume) and Signature 2 (increased striatal volume)—could be replicated and detected at the population level. Using independent samples of schizophrenia patients, typically developing youth, and healthy adults, the researchers quantified signature expression using machine learning. Signature 1 was significantly more common in youth with psychosis-spectrum symptoms and was associated with poorer cognitive performance and elevated polygenic risk scores. Signature 2 frequency was similar between typically developing and symptomatic youth and did not show elevated genetic risk. These findings suggest distinct neurobiological vulnerabilities underlying schizophrenia risk in the general population.

Introduction: Addressing Neurobiological Heterogeneity

Schizophrenia is a highly heterogeneous disorder. Clinical symptoms, cognitive profiles, and brain structures vary significantly between patients, often confounding traditional case-control studies that treat "all patients" as a single group. This study sought to replicate two previously identified neuroanatomical subtypes (signatures) in independent samples and investigate their presence in the general population to determine if they signal biological vulnerability to psychosis before clinical diagnosis.

Methods and Datasets

The researchers employed a semi-supervised machine learning pipeline to identify and quantify brain structural patterns:

  • HYDRA (Heterogeneity through Discriminative Analysis): Used to find distinct patterns within patient groups that differentiate them from controls.
  • Signature Quantification: Support Vector Machines (SVM) estimated the expression strength of two previously identified signatures:
  • Signature 1 (S1): Characterized by widespread reductions in gray and white matter volume.
  • Signature 2 (S2): Characterized by an increase in the volume of the striatum and internal capsule.
Neuroanatomical signatures of schizophrenia and their expression in population samples.

Key Results

Successful Replication and Population Prevalence

The two-subtype model was successfully replicated in the independent patient sample (58% S1, 42% S2). Notably, these signatures are not exclusive to clinical diagnoses; approximately 23-24% of typically developing youth express one of these signatures, supporting the concept of "schizotaxia"—a biological state of risk existing without overt symptoms.

Psychosis and Cognitive Divergence

In the youth cohort (PNC), S1 was significantly more prevalent in individuals reporting psychosis-spectrum symptoms (39.8%) compared to typically developing peers (23.03%). S2 frequency remained similar across groups. Cognitively, S1 was consistently associated with poorer efficiency and accuracy in both youth and adults (z-stat = -4.64 for efficiency). In contrast, S2 expression in adults showed a positive correlation with fluid intelligence (ρ = 0.17), suggesting it may represent a distinct pathological or even compensatory pathway.

Genetic Validation

Adults in the UK Biobank expressing S1 exhibited significantly higher polygenic risk scores for schizophrenia (z-stat = 2.69). Signature 2 did not show this elevated genetic burden, indicating that S1 may more closely align with the inherited genetic risk typically associated with the disorder.

Discussion and Future Directions

While these signatures provide critical clues into the pathophysiology of schizophrenia, several limitations remain. The cross-sectional nature of the data prevents definitive conclusions about whether individuals with these signatures will eventually develop clinical schizophrenia. Furthermore, while S1 is linked to volume loss, the functional implications of S2's enlarged striatum require further investigation via fMRI. Future longitudinal studies are necessary to determine the predictive value of these neuroanatomical markers for clinical outcomes.

Summary updated

Abstract

The authors successfully replicated two neuroanatomical signatures of schizophrenia and describe their prevalence in population-based samples of youths and adults. They further demonstrated distinct relationships of these signatures with psychosis symptoms, cognition, and genetic risk, potentially reflecting underlying neurobiological vulnerability.
BibTeX
@inproceedings{chand2022schizophrenia,
  author = {Ganesh B. Chand and Pankhuri Singhal and Dominic Dwyer and Junhao Wen and Güray Erus and Jimit Doshi and Dhivya Srinivasan and Elizabeth Mamourian and Erdem Varol and Aristeidis Sotiras and Gyujoon Hwang and Paola Dazzan and René S. Kahn and Hugo G. Schnack and Marcus V. Zanetti and Eva Meisenzahl and Geraldo F. Busatto and Benedicto Crespo‐Facorro and Christos Pantelis and Stephen J. Wood and Chuanjun Zhuo and Russell T. Shinohara and Haochang Shou and Yong Fan and Nikolaos Koutsouleris and Antonia N. Kaczkurkin and Tyler M. Moore and Anurag Verma and Monica E. Calkins and Raquel E. Gur and Ruben C. Gur and Marylyn D. Ritchie and Theodore D. Satterthwaite and Daniel H. Wolf and Christos Davatzikos},
  title = {{Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population}},
  booktitle = {American},
  year = {2022},
  doi = {10.1176/appi.ajp.21070686},
}

Loading related content...

Figure